Showing results (61-70 of 82) with videos related to
Sort By:
Pageof 9
Journal of the American Heart Association|May 31, 2017
Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes MellitusEmil Wolsk, Brian Claggett, Marc A Pfeffer, et al.Journal of Diabetes Research|January 17, 2019
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease DurationJelena P Seferovic, Rhonda Bentley-Lewis, Brian Claggett, et al.Diabetes Care|March 6, 2014
Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trialKaren L Margolis, Patrick J O'Connor, Timothy M Morgan, et al.Diabetes Care|February 28, 2014
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemiaLouise Bordeleau, Natalia Yakubovich, Gilles R Dagenais, et al.The New England Journal of Medicine|December 3, 2015
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary SyndromeMarc A Pfeffer, Brian Claggett, Rafael Diaz, et al.Journal of the American College of Cardiology|September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHFAnkeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.Diabetes Care|October 15, 2015
Insulin Dose and Cardiovascular Mortality in the ACCORD TrialElias S Siraj, Daniel J Rubin, Matthew C Riddle, et al.European Journal of Heart Failure|March 27, 2020
Hyperglycaemia, ejection fraction and the risk of heart failure or cardiovascular death in patients with type 2 diabetes and a recent acute coronary syndromeSung-Hee Shin, Brian Claggett, Marc A Pfeffer, et al.American Heart Journal|May 13, 2015
Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placeboRhonda Bentley-Lewis, David Aguilar, Matthew C Riddle, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|March 10, 2010
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudyWalter T Ambrosius, Ronald P Danis, David C Goff, et al.Pageof 9